Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eiger Biopharmaceuticals, Inc. (EIGRQ)
:EIGRQ
Holding EIGRQ?
Track your performance easily
EIGRQ Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eiger Biopharmaceuticals News
PremiumCompany Announcements
Eiger BioPharmaceuticals Files for Chapter 11, Warns Investors
PremiumCompany Announcements
Eiger BioPharmaceuticals Issues Chapter 11 Financial Update
PremiumCompany Announcements
Eiger BioPharmaceuticals Announces Bankruptcy and Liquidation Plan
PremiumCompany Announcements
Eiger BioPharmaceuticals Issues Cautionary Chapter 11 Reports
PremiumCompany Announcements
Eiger BioPharmaceuticals Cautions Investors Amid Bankruptcy
PremiumCompany Announcements
Eiger Biopharmaceuticals CFO Exits Amid Bankruptcy ReorganizationOptions Prices
Currently, No data available
---
Ownership Overview
― Insiders
0.02% Mutual Funds
― Other Institutional Investors
99.61% Public Companies and
Individual Investors
EIGRQ FAQ
What was Eiger Biopharmaceuticals, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Eiger Biopharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is Eiger Biopharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eiger Biopharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Eiger Biopharmaceuticals, Inc. overvalued?
According to Wall Street analysts Eiger Biopharmaceuticals, Inc.’s price is currently Undervalued.
Does Eiger Biopharmaceuticals, Inc. pay dividends?
Eiger Biopharmaceuticals, Inc. does not currently pay dividends.
What is Eiger Biopharmaceuticals, Inc.’s EPS estimate?
Eiger Biopharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eiger Biopharmaceuticals, Inc. have?
Currently, no data Available
What happened to Eiger Biopharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eiger Biopharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in EIGRQ
---
---